Long-term clinical experience with the omnicarbon prosthetic valve Salvador Torregrosa, MD, Jesús Gómez-Plana, MD, Francisco J Valera, MD, José Caffarena, MD, PhD, José M Maroñas, MD, PhD, Francisco Garcı́a-Sánchez, MD, PhD, José Peris, MD, PhD, Ramón Frı́as, MD, PhD, José M Caffarena, MD, PhD The Annals of Thoracic Surgery Volume 68, Issue 3, Pages 881-886 (September 1999) DOI: 10.1016/S0003-4975(99)00557-3
Fig 1 Distribution of patients by age. The Annals of Thoracic Surgery 1999 68, 881-886DOI: (10.1016/S0003-4975(99)00557-3)
Fig 2 Distribution of valve sizes. The Annals of Thoracic Surgery 1999 68, 881-886DOI: (10.1016/S0003-4975(99)00557-3)
Fig 3 Distribution of type of valve replacement by sex. (AVR = aortic valve replacement; DVR = double-valve replacement [AVR + MVR]; MVR = mitral valve replacement.) The Annals of Thoracic Surgery 1999 68, 881-886DOI: (10.1016/S0003-4975(99)00557-3)
Fig 4 Overall actuarial survival curve (at 10 years). The numbers below the time axis indicate patients at risk (at 2-year intervals). (AVR = aortic valve replacement; DVR = double-valve replacement [AVR + MVR]; MVR = mitral valve replacement.) The Annals of Thoracic Surgery 1999 68, 881-886DOI: (10.1016/S0003-4975(99)00557-3)
Fig 5 Actuarial curves of freedom from valve-related death. The numbers below the time axis indicate patients at risk (at 2-year intervals). (AVR = aortic valve replacement; DVR = double-valve replacement [AVR + MVR]; MVR = mitral valve replacement.) The Annals of Thoracic Surgery 1999 68, 881-886DOI: (10.1016/S0003-4975(99)00557-3)